Compare ImmunityBio Inc. Common Stock (IBRX) vs Riot Platforms Inc (RIOT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs Riot Platforms Inc — how do they compare? ImmunityBio Inc. Common Stock trades at $10.25 (market cap $10.51B), while Riot Platforms Inc trades at $16.69 (market cap $6.32B). The key difference: ImmunityBio Inc. Common Stock is the larger of the two by market cap, and ImmunityBio Inc. Common Stock is trading nearer its 52-week high, Riot Platforms Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and Riot Platforms Inc for 16 Days on average.
| IBRX | RIOT | |
|---|---|---|
Market Cap | $10.51B | $6.32B |
Volume | 10,445,785 | 30,571,756 |
Sector | Health | Financials |
52-Week High | $11.55 | $28.67 |
52-Week Low | $1.98 | $11.83 |
Typical Hold Time | 0 Days | 16 Days |
Enterprise Value | $10.97B | $6.73B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
RIOT trades at $18.54, down 2.06% with bearish technical signals despite strong analyst support. The company shows concerning fundamentals with a -196.28% net income margin and negative cash flow from operations of -$573M in 2025. However, RIOT is pivoting to AI data center services, securing $9.8B in long-term contracts through 2048 with major tenants including AMD, potentially transforming its revenue model.
While analyst consensus remains strongly bullish with 94.74% buy ratings and $31.64 price target, investors face significant execution risks in the business model transition. The stock offers substantial upside potential if AI initiatives succeed but carries high volatility given current unprofitability and competitive pressures in both Bitcoin mining and data center markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About Riot Platforms Inc
Riot Platforms, Inc. is a Bitcoin mining company that focuses on building, operating, and expanding large-scale infrastructure for digital asset mining in North America. The company's operations include Bitcoin mining, data center hosting, and engineering solutions. Riot's strategy emphasizes vertical integration to maximize efficiency and scale its mining capacity, aiming to be a leader in the global Bitcoin and digital infrastructure industry.
Read more on RIOT →
